Company Filing History:
Years Active: 2024
Title: Elodie Sune: Innovator in Polynucleotide Synthesis
Introduction
Elodie Sune is a prominent inventor based in Le Kremlin-Bicétre, France. She has made significant contributions to the field of biotechnology, particularly in the area of polynucleotide synthesis. Her innovative work has led to the development of a unique patent that enhances the efficiency of nucleic acid synthesis.
Latest Patents
Elodie Sune holds a patent for "Terminal deoxynucleotidyl transferase variants and uses thereof." This invention focuses on terminal deoxynucleotidyltransferase (TdT) variants that possess specific amino acid sequences and substitutions. These variants are capable of template-free extension of a polynucleotide and exhibit enhanced stability or efficiency in incorporating 3′-O-blocked nucleoside triphosphates into a polynucleotide. The invention also outlines the use of these TdT variants for synthesizing polynucleotides of predetermined sequences.
Career Highlights
Elodie Sune is currently employed at Dna Script, a company known for its advancements in DNA synthesis technology. Her work at Dna Script has positioned her as a key player in the biotechnology sector, contributing to innovative solutions in genetic research and applications.
Collaborations
Elodie collaborates with talented individuals such as Elise Champion and Jéröme Loc'h. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.
Conclusion
Elodie Sune's contributions to the field of biotechnology through her patent and work at Dna Script highlight her role as an influential inventor. Her advancements in polynucleotide synthesis are paving the way for future innovations in genetic research.